SCHEMBL21164790

SCHEMBL21164790

CC(C)(S)c1ncco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL683343 0.80
SCHEMBL9371348 0.76
SCHEMBL14157628 0.76
SCHEMBL14152113 0.76
SCHEMBL85641 0.76 CNR2 (0.30)
SCHEMBL3377554 0.76
SCHEMBL24615096 0.76
SCHEMBL10280220 0.74 HRH3 (0.31)
SCHEMBL2629431 0.73
SCHEMBL31582646 0.72 CNR2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163455-A1 GLP-1 Receptor Agonists and Uses Thereof PFIZER INC. (US) 2021-06-03 US disclosed
US-10392422-B2 Macrocyclic broad spectrum antibiotics RQX PHARMACEUTICALS, INC. (US) 2019-08-27 US disclosed
US-10351595-B2 2019-07-16 US disclosed